These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29742327)

  • 21. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma.
    Imperatore V; Pinto AM; Gelli E; Trevisson E; Morbidoni V; Frullanti E; Hadjistilianou T; De Francesco S; Toti P; Gusson E; Roversi G; Accogli A; Capra V; Mencarelli MA; Renieri A; Ariani F
    Eur J Hum Genet; 2018 Jul; 26(7):1026-1037. PubMed ID: 29662154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
    Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
    Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.
    Liu H; Cao B; Zhao Y; Liang H; Liu X
    Cancer Biomark; 2018; 22(4):621-629. PubMed ID: 29843209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
    Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
    Sun Z; Zhang A; Jiang T; Du Z; Che C; Wang F
    Int J Clin Exp Pathol; 2015; 8(11):14521-7. PubMed ID: 26823772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
    Xing L; Zhang L; Feng Y; Cui Z; Ding L
    Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-course gene profiling and networks in demethylated retinoblastoma cell line.
    Malusa F; Taranta M; Zaki N; Cinti C; Capobianco E
    Oncotarget; 2015 Sep; 6(27):23688-707. PubMed ID: 26143641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of High Mobility Group Box-1 Protein (HMGB1) with Clinicopathological Parameters in Primary Retinoblastoma.
    Singh MK; Singh L; Pushker N; Sen S; Sharma A; Chauhan FA; Kashyap S
    Pathol Oncol Res; 2015 Sep; 21(4):1237-42. PubMed ID: 26118980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6.
    Li J; You X
    Oncol Rep; 2018 Sep; 40(3):1777-1786. PubMed ID: 30015924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human retinoblastoma susceptibility gene (RB1): an evolutionary story in primates.
    Viana MC; Tavares WC; Brant AC; Boroni M; Seuánez HN
    Mamm Genome; 2017 Jun; 28(5-6):198-212. PubMed ID: 28401291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.
    Li X; Yang L; Shuai T; Piao T; Wang R
    Biomed Pharmacother; 2016 Aug; 82():247-55. PubMed ID: 27470361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma.
    Galardi A; Stathopoulos C; Colletti M; Lavarello C; Russo I; Cozza R; Romanzo A; Carcaboso AM; Locatelli F; Petretto A; Munier FL; Di Giannatale A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
    Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
    J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
    Vasaikar SV; Straub P; Wang J; Zhang B
    Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic analysis results of patients with a retinoblastoma refractory to systemic chemotherapy].
    Ruiz del Río N; Abelairas Gómez JM; Alonso García de la Rosa FJ; Peralta Calvo JM; de las Heras Martín A
    Arch Soc Esp Oftalmol; 2015 Sep; 90(9):414-20. PubMed ID: 25817468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
    Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.
    Rajasekaran S; Siddiqui J; Rakijas J; Nicolay B; Lin C; Khan E; Patel R; Morris R; Wyler E; Boukhali M; Balasubramanyam J; Ranjith Kumar R; Van Rechem C; Vogel C; Elchuri SV; Landthaler M; Obermayer B; Haas W; Dyson N; Miles W
    Commun Biol; 2021 Aug; 4(1):977. PubMed ID: 34404904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.